SMO ClinPlus CO.,LTD. provides site management services in research and development in pharmaceuticals, medical devices, and health-related products in China. It offers clinical trial site management organization services to pharmaceuticals, medical devices, CRO companies, etc. The company offers preliminary modeling and preparation plans, trial site initiation, on-site execution, and project management services. SMO ClinPlus CO.,LTD. was founded in 2009 and is based in Huangpu, China.
Frequently asked questions
What sector does SMO ClinPlus Co. Ltd. (301257) operate in?
SMO ClinPlus Co. Ltd. belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is SMO ClinPlus Co. Ltd. (301257) current stock price?
As of the latest data, SMO ClinPlus Co. Ltd. stock price is CN¥52.80, with a previous close of CN¥50.31. SMO ClinPlus Co. Ltd. gained CN¥2.49 in the last trading session, representing a 4.95% increase.
What is SMO ClinPlus Co. Ltd. (301257) current market capitalization?
SMO ClinPlus Co. Ltd. market cap is approximately 4.17 billion.
What is SMO ClinPlus Co. Ltd. (301257) Earnings Per Share (EPS)?
The trailing EPS is CN¥1.44, and the forward EPS is CN¥1.57.
What is SMO ClinPlus Co. Ltd. (301257) Price-to-Earnings (P/E) ratio?
SMO ClinPlus Co. Ltd. current P/E ratio is 36.67, with a forward P/E of 33.63.
Does SMO ClinPlus Co. Ltd. (301257) pay dividends?
Yes. SMO ClinPlus Co. Ltd. pays semiannual dividends with an annualized yield of 0.3% and an estimated annual payout of CN¥0.16 per share.
When is the next ex-dividend date for SMO ClinPlus Co. Ltd. (301257)?
The next ex-dividend date is scheduled for January 09, 2027.
What is SMO ClinPlus Co. Ltd. (301257) beta (volatility) score?
SMO ClinPlus Co. Ltd. has a beta of 0.829, meaning its volatility is roughly in line with the market.
